Clinical Updates
Obesity Clinical Update: 29 September 2026
Daily intelligence on obesity pharmacotherapy trials, conference disclosures, and emerging data — covering EASD 2026, ObesityWeek, and late-breaking Phase 3 readouts.
29 Sept 2026Read
For healthcare professionals
Clinical education on obesity for UK HCPs
Evidence-based tools, guidelines, and educational resources to support UK healthcare professionals in identifying, assessing, and managing obesity in clinical practice.
Obesity courses for HCPsClinical education topics
Recognising obesity as a chronic disease
Obesity is a complex, chronic, relapsing, and progressive disease — not a lifestyle choice. The World Obesity Federation and NICE both recognise obesity as a medical condition requiring long-term clinical management. UK healthcare professionals play a critical role in shifting the narrative away from blame and towards evidence-based care.
Assessment and identification
NICE recommends using BMI as an initial screening tool, with waist circumference used alongside BMI to assess cardiometabolic risk — particularly in people from South Asian, Chinese, and other high-risk ethnic backgrounds. A holistic assessment should include medical history, comorbidities, psychological factors, and readiness to change.
Weight management pathways
The NHS Tier framework provides a structured approach to weight management: Tier 1 (universal prevention), Tier 2 (community lifestyle programmes), Tier 3 (specialist multidisciplinary services), and Tier 4 (bariatric surgery). Referral criteria and service availability vary across England, Scotland, Wales, and Northern Ireland.
Pharmacological interventions
NICE NG238 provides updated guidance on pharmacological treatments for obesity, including GLP-1 receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda). These should be used as an adjunct to lifestyle intervention in eligible patients, with clear criteria for initiation, monitoring, and discontinuation.
Addressing weight stigma in clinical settings
Weight stigma — negative attitudes and stereotypes about people with obesity — is prevalent in healthcare settings and can deter patients from seeking help. Using person-first language ('person living with obesity' rather than 'obese person'), adopting a non-judgemental approach, and ensuring clinical environments are accessible and inclusive are all recommended by NICE and Obesity UK.
Psychological support and integrated care
NICE guidelines recommend that psychological assessment and support should be integral to weight management pathways. Cognitive behavioural therapy (CBT), motivational interviewing, and acceptance and commitment therapy (ACT) have evidence for improving outcomes in people with obesity. Integrated care systems (ICSs) in England are increasingly commissioning joined-up physical and mental health services.
Clinical intelligence
Latest obesity clinical updates
Clinical Updates
Obesity Clinical Update: 11 September 2026
NICE lower BMI threshold guidance — final draft expected October. NHS tirzepatide 8-month data: 220,000 patients, 6-month outcomes published. UKCO 2026 programme announced. Semaglutide MASH MHRA review update.
11 Sept 2026Read
Clinical Updates
Obesity Clinical Update: 21 August 2026
Orforglipron FDA approved 14 August — landmark for oral obesity pharmacotherapy. TRIUMPH-1 retatrutide Phase 3 data expected October. NHS tirzepatide 7-month data: 200,000 patients.
21 Aug 2026Read
Browse all UK obesity resources
Access our full library of NHS, NICE, and research resources for patients and clinicians.